Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05463705 · ClinicalTrials.gov registry record · NA
Addressing Diffusion of Responsibility and Prescribing Burden to Improve Use of Diabetes Medications
A NA study of Diabetes and SGLT-2i and GLP-1RA Therapies, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 1,580
- Enrollment target
- 1
- Study location
NCT05463705 is a NA study of Diabetes and SGLT-2i and GLP-1RA Therapies that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 1,580 participants, below the 3,024-participant average among 338 other Diabetes trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05463705, a NA study of Diabetes and SGLT-2i and GLP-1RA Therapies, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,580 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the impact of addressing diffusion of responsibility with and without additional reduction of prescribing burden on SGLT-2i and GLP-1RAs prescribing compared to usual care. Population: MGH primary care physicians caring for at least 2 eligible patients. Eligible patients are individuals age18 years or older with type 2 diabetes and HbA1c \>7.5% and a compelling indication for an SGLT-2i or GLP-1RA (including cardiovascular disease, kidney disease, heart failure, or obesity), who are not already prescribed one of these therapies. Intervention: PCPs will be randomized to one of three arms: 1) intervention to address diffusion of responsibility, 2) Intervention to address diffusion of responsibility with additional simplification of prescribing, 3) usual care.
Conditions Studied
Interventions
- BEHAVIORAL Intervention to address diffusion of responsibility
- BEHAVIORAL Intervention to address diffusion of responsibility + simplification of prescribing
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,580 participants |
| Start Date | 2023-05-04 |
| Est. Completion | 2024-08-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05463705
The ClinicalTrials.gov registry entry for NCT05463705 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,580 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,024-participant average among 338 other Diabetes trials with a reported enrollment target (48% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Intervention to address diffusion of responsibility is the first listed.
NCT05463705 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05463705 about?
NCT05463705 is a clinical study titled "Addressing Diffusion of Responsibility and Prescribing Burden to Improve Use of Diabetes Medications". This study will test the impact of addressing diffusion of responsibility with and without additional reduction of prescribing burden on SGLT-2i and GLP-1RAs prescribing compared to usual care. Population: MGH primary care physicians caring for at least 2 eligible patients. Eligible patients are in...
What is the current status of trial NCT05463705?
This trial is currently completed. It is a NA study. The enrollment target is 1,580 participants. The study started on 2023-05-04. Estimated completion is 2024-08-22.
What conditions does trial NCT05463705 study?
This clinical trial studies the following conditions: Diabetes, SGLT-2i and GLP-1RA Therapies, Diffusion of Responsibility, Prescribing Burden.
What interventions are being tested in trial NCT05463705?
The interventions under investigation include: Intervention to address diffusion of responsibility (BEHAVIORAL), Intervention to address diffusion of responsibility + simplification of prescribing (BEHAVIORAL).
Who is sponsoring clinical trial NCT05463705?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05463705 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.